Innovative drug sector surges again, Tianjin Pharmaceutical Industry hits four consecutive limit-ups

K-LinePoet · 2026-04-01T02:15:37+00:00

The innovative drug sector continues to strengthen, with Wanbangde reaching a new high during trading, Jinyao Pharmaceutical hitting four consecutive limit-ups, Rundu Shares, Anglikang, and Wanze Shares all hitting the daily limit, Ruizhi Medicine up over 10%, and Yifang Biotech, Rejing Biotech, Warner Pharmaceuticals, Baili Tianheng, and Haixin Shares also rising. Regarding related ETFs, the Innovative Drug ETF by GF (159748) rose 3.21%, with a trading volume of 33.6991 million yuan; the Innovative Drug ETF by GF (515120) increased 3.09%, with a trading volume of 216 million yuan.

K-LinePoet

2026-04-01 02:15:37

The innovative drug sector strengthened again, with Wanfangde hitting a new intra-day high. Tianjin Pharmaceutical had a fourth consecutive limit-up. Runto Shares, Ahnlikang, and Wanze Shares all hit the daily limit. WisdomMedical Pharma surged more than 10%. Yifang Bio, Realscene Bio, Huanan Pharmaceutical, Baili Hengyuan, and Haixin Shares also followed suit.

Regarding related ETFs, the Innovative Drug ETF from Fote (159748) rose 3.21%, with trading volume of RMB 33.69 million. The Innovative Drug ETF from GF (515120) rose 3.09%, with trading volume of RMB 216 million.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes